dichlororibofuranosylbenzimidazole has been researched along with HIV in 3 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, Z | 1 |
Klatt, A | 1 |
Henderson, AJ | 1 |
Gilmour, DS | 1 |
Yamaguchi, Y | 1 |
Wada, T | 1 |
Handa, H | 1 |
Isel, C | 1 |
Karn, J | 1 |
1 review available for dichlororibofuranosylbenzimidazole and HIV
Article | Year |
---|---|
Interplay between positive and negative elongation factors: drawing a new view of DRB.
Topics: Dichlororibofuranosylbenzimidazole; Enzyme Inhibitors; Fungal Proteins; Gene Expression Regulation; | 1998 |
2 other studies available for dichlororibofuranosylbenzimidazole and HIV
Article | Year |
---|---|
Transcription termination factor Pcf11 limits the processivity of Pol II on an HIV provirus to repress gene expression.
Topics: Animals; Cells, Cultured; Chromatin Immunoprecipitation; Dichlororibofuranosylbenzimidazole; Down-Re | 2007 |
Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
Topics: Adenosine Triphosphate; Alkaline Phosphatase; Cyclin T; Cyclin-Dependent Kinase 9; Cyclin-Dependent | 1999 |